Literature DB >> 29947169

Meta-analyses and blood pressure goals.

Staffan Björck1, Karin Manhem2, Annika Rosengren3,4, Samuel Adamsson Eryd1,3, Soffia Gudbjörnsdottir1,3, Stefan Franzén1.   

Abstract

Entities:  

Year:  2018        PMID： 29947169      PMCID： PMC8031211          DOI： 10.1111/jch.13327

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  22 in total

Review 1.  Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients.

Authors:  Chirag Bavishi; Sripal Bangalore; Franz H Messerli
Journal:  J Am Coll Cardiol       Date:  2017-02-07       Impact factor: 24.094

Review 2.  Quality of Meta-Analyses for Randomized Trials in the Field of Hypertension: an Updated and Improved Systematic Review.

Authors:  George C Roush; Fiorella Perez; Ramy Abdelfattah; Andrew Prindle; Elie Jean; Tanveer Singh; John B Kostis; William J Kostis; William J Elliott; Jesse A Berlin
Journal:  Curr Hypertens Rep       Date:  2017-09       Impact factor: 5.369

3.  The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.

Authors:  Caroline A Daly; Kim M Fox; Willem J Remme; Michel E Bertrand; Roberto Ferrari; Maarten L Simoons
Journal:  Eur Heart J       Date:  2005-04-28       Impact factor: 29.983

Review 4.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

5.  Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.

Authors:  Sripal Bangalore; Bora Toklu; Eugenia Gianos; Arthur Schwartzbard; Howard Weintraub; Gbenga Ogedegbe; Franz H Messerli
Journal:  Am J Med       Date:  2017-01-19       Impact factor: 4.965

6.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

7.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

8.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

9.  The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

Authors:  L M Laffel; J B McGill; D J Gans
Journal:  Am J Med       Date:  1995-11       Impact factor: 4.965

Review 10.  Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis.

Authors:  Jessica Weiss; Michele Freeman; Allison Low; Rochelle Fu; Amy Kerfoot; Robin Paynter; Makalapua Motu'apuaka; Karli Kondo; Devan Kansagara
Journal:  Ann Intern Med       Date:  2017-01-17       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.